Business Information
The group's principal activities are the development, manufacture and marketing of diagnostic test kits used for the clinical laboratory and point-of-care segments of the diagnostic market. The line of test kits are mostly used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders and autoimmune diseases. The group's products are in areas of enzyme immunoassays, fluorescence assays, rapid assays, western blot, clinical chemistry and haemostasis using the brand names such as Amax, Biopool, Captia, Microtrak, Mardx, Recombigen, Bartels, Serocard, Unigold, Capillus, EZ HDL and EZ LDL. The group operates in 80 countries including Ireland, the United States and Germany.
|
|
Name |
Title
|
Email
|
| Ronan O'Caoimh | Chmn., CEO, Co - Founder | N/A | | Rory Nealon | Dir., CFO | N/A | | Brendan Farrell | Dir., Pres. | N/A | | Denis Burger | Dir. | N/A | | Jim Walsh | Dir., Non Exec. Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 118,674 | 3,276 | | 2005 | 98,721 | 2,582 | | 2004 | 79,944 | 4,048
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
